JP2022548270A5 - - Google Patents
Info
- Publication number
- JP2022548270A5 JP2022548270A5 JP2022516687A JP2022516687A JP2022548270A5 JP 2022548270 A5 JP2022548270 A5 JP 2022548270A5 JP 2022516687 A JP2022516687 A JP 2022516687A JP 2022516687 A JP2022516687 A JP 2022516687A JP 2022548270 A5 JP2022548270 A5 JP 2022548270A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899953P | 2019-09-13 | 2019-09-13 | |
| US62/899,953 | 2019-09-13 | ||
| PCT/US2020/050551 WO2021050991A1 (en) | 2019-09-13 | 2020-09-11 | Compositions and methods for treatment of friedreich's ataxia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548270A JP2022548270A (ja) | 2022-11-17 |
| JPWO2021050991A5 JPWO2021050991A5 (https=) | 2023-07-25 |
| JP2022548270A5 true JP2022548270A5 (https=) | 2023-07-25 |
Family
ID=74865919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516687A Pending JP2022548270A (ja) | 2019-09-13 | 2020-09-11 | フリードライヒ運動失調症の治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220211737A1 (https=) |
| EP (1) | EP4028027A4 (https=) |
| JP (1) | JP2022548270A (https=) |
| AU (1) | AU2020346914A1 (https=) |
| CA (1) | CA3151073A1 (https=) |
| WO (1) | WO2021050991A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4426845A4 (en) * | 2021-11-01 | 2025-10-01 | Univ Florida | AAV-MEDIATED THERAPIES FOR VISION LOSS ASSOCIATED WITH FRIEDREICH ATAXIA |
| WO2024097772A1 (en) * | 2022-11-01 | 2024-05-10 | Lacerta Therapeutics, Inc. | Compositions and methods for treatment of friedreich's ataxia |
| WO2025157942A2 (en) * | 2024-01-23 | 2025-07-31 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Encapsulated engineered cells for treating a disease or condition affecting the nervous system |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3245221A4 (en) * | 2015-01-16 | 2018-06-13 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| WO2016172659A1 (en) * | 2015-04-24 | 2016-10-27 | University Of Florida Research Foundation, Inc. | Aav vector for treatment of friedreich's ataxia |
| WO2017075338A2 (en) * | 2015-10-29 | 2017-05-04 | Voyager Therapeutics, Inc. | Delivery of central nervous system targeting polynucleotides |
| RU2021102893A (ru) * | 2015-11-05 | 2021-03-03 | Бамбу Терапьютикс, Инк. | Модифицированные гены атаксии фридрейха и векторы для генной терапии |
| CN110139933B (zh) * | 2016-11-09 | 2024-03-08 | 英特瑞克斯顿股份有限公司 | 共济蛋白表达构建体 |
| EP3641834B1 (en) * | 2017-06-19 | 2023-10-04 | Translate Bio, Inc. | Messenger rna therapy for the treatment of friedreich's ataxia |
| WO2019000093A1 (en) * | 2017-06-29 | 2019-01-03 | UNIVERSITé LAVAL | PLATINUM TALE AND USE THEREOF TO INCREASE THE EXPRESSION OF FRATAXIN |
| WO2019076973A1 (en) * | 2017-10-17 | 2019-04-25 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | VECTORS FOR THE TREATMENT OF FRIEDREICH ATAXIA |
-
2020
- 2020-09-11 JP JP2022516687A patent/JP2022548270A/ja active Pending
- 2020-09-11 AU AU2020346914A patent/AU2020346914A1/en active Pending
- 2020-09-11 US US17/434,318 patent/US20220211737A1/en not_active Abandoned
- 2020-09-11 CA CA3151073A patent/CA3151073A1/en active Pending
- 2020-09-11 WO PCT/US2020/050551 patent/WO2021050991A1/en not_active Ceased
- 2020-09-11 EP EP20863569.8A patent/EP4028027A4/en active Pending